Avalo Therapeutics, Inc. · NASDAQ:AVTX

Affinity Asset Advisors, LLC reported a 5.50% stake in Avalo Therapeutics, Inc. (Schedule 13G/A)

Event Jun 30, 2026 · Filed Aug 13, 2026

Affinity Asset Advisors, LLC reported a 5.50% stake in Avalo Therapeutics, Inc., 2,900,000 shares, as a passive investor on Jun 30, 2026. Filed Aug 13, 2026 (Schedule 13G/A).

Stake
5.50%
Shares
2,900,000
Intent
Passive
What changed
Stake changed
Filed together
2 holders

The filing in full

HolderStakeShares
Affinity Asset Advisors, LLC5.50%2,900,000
Michael Cho5.50%2,900,000

Source

View original at SEC

Related